The effectiveness of second- and-third-line biologics in perianal Crohn’s disease—a multicenter propensity score-matched study

Uria Shani, Monica State, Radu Bogdan Mateescu, Ana-Maria Davidoiu, Lucian Negreanu, Isabel Silva, Fernando Magro, Charlie W Lees, Nikolas Plevris, Xavier Roblin, Sílvia Castellet-Farrús, Yago Gonzalez Lama, Shanshan Wang, Carolina Abad, Nicola Imperatore, Milan Lukas, Gabriela Vojtechova, Offir Ukashi, Shomron Ben-Horin, Stephane Nancey, Edoardo Savarino, Kamila Stawczyk-Eder, Piotr Eder, Alexandros Toskas, Nikolaos Kamperidis, Naila Arebi, Bernadett Farkas, Klaudia Farkas, Barbora Pipek, Premysl Falt, Konstantinos Karmiris, Pinelopi Nikolaou, Zeljko Krznaric, Marko Brinar, Frank Hoentjen, Lisa van Lierop, Manuel Barreiro-de Acosta, Marta Zaborowska, Edyta Zagorowicz, Daniela Pugliese, Giuseppe Cuccia, Marie Truyens, Uri Kopylov

Open source

DOI: 10.1093/ecco-jcc/jjaf099
Published: 2025-06
Container: Journal of Crohn's and Colitis
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ecco-jcc/jjaf099,
  title = {The effectiveness of second- and-third-line biologics in perianal Crohn’s disease—a multicenter propensity score-matched study},
  author = {Uria Shani and Monica State and Radu Bogdan Mateescu and Ana-Maria Davidoiu and Lucian Negreanu and Isabel Silva and Fernando Magro and Charlie W Lees and Nikolas Plevris and Xavier Roblin and Sílvia Castellet-Farrús and Yago Gonzalez Lama and Shanshan Wang and Carolina Abad and Nicola Imperatore and Milan Lukas and Gabriela Vojtechova and Offir Ukashi and Shomron Ben-Horin and Stephane Nancey and Edoardo Savarino and Kamila Stawczyk-Eder and Piotr Eder and Alexandros Toskas and Nikolaos Kamperidis and Naila Arebi and Bernadett Farkas and Klaudia Farkas and Barbora Pipek and Premysl Falt and Konstantinos Karmiris and Pinelopi Nikolaou and Zeljko Krznaric and Marko Brinar and Frank Hoentjen and Lisa van Lierop and Manuel Barreiro-de Acosta and Marta Zaborowska and Edyta Zagorowicz and Daniela Pugliese and Giuseppe Cuccia and Marie Truyens and Uri Kopylov},
  year = {2025},
  journal = {Journal of Crohn's and Colitis},
  doi = {10.1093/ecco-jcc/jjaf099},
  url = {https://doi.org/10.1093/ecco-jcc/jjaf099}
}

RIS

TY  - JOUR
TI  - The effectiveness of second- and-third-line biologics in perianal Crohn’s disease—a multicenter propensity score-matched study
AU  - Uria Shani
AU  - Monica State
AU  - Radu Bogdan Mateescu
AU  - Ana-Maria Davidoiu
AU  - Lucian Negreanu
AU  - Isabel Silva
AU  - Fernando Magro
AU  - Charlie W Lees
AU  - Nikolas Plevris
AU  - Xavier Roblin
AU  - Sílvia Castellet-Farrús
AU  - Yago Gonzalez Lama
AU  - Shanshan Wang
AU  - Carolina Abad
AU  - Nicola Imperatore
AU  - Milan Lukas
AU  - Gabriela Vojtechova
AU  - Offir Ukashi
AU  - Shomron Ben-Horin
AU  - Stephane Nancey
AU  - Edoardo Savarino
AU  - Kamila Stawczyk-Eder
AU  - Piotr Eder
AU  - Alexandros Toskas
AU  - Nikolaos Kamperidis
AU  - Naila Arebi
AU  - Bernadett Farkas
AU  - Klaudia Farkas
AU  - Barbora Pipek
AU  - Premysl Falt
AU  - Konstantinos Karmiris
AU  - Pinelopi Nikolaou
AU  - Zeljko Krznaric
AU  - Marko Brinar
AU  - Frank Hoentjen
AU  - Lisa van Lierop
AU  - Manuel Barreiro-de Acosta
AU  - Marta Zaborowska
AU  - Edyta Zagorowicz
AU  - Daniela Pugliese
AU  - Giuseppe Cuccia
AU  - Marie Truyens
AU  - Uri Kopylov
PY  - 2025
JO  - Journal of Crohn's and Colitis
DO  - 10.1093/ecco-jcc/jjaf099
UR  - https://doi.org/10.1093/ecco-jcc/jjaf099
ER  -

APA

Shani, U., State, M., Mateescu, R. B., Davidoiu, A., Negreanu, L., Silva, I., Magro, F., Lees, C. W., Plevris, N., Roblin, X., Castellet-Farrús, S., Lama, Y. G., Wang, S., Abad, C., Imperatore, N., Lukas, M., Vojtechova, G., Ukashi, O., Ben-Horin, S., Nancey, S., Savarino, E., Stawczyk-Eder, K., Eder, P., Toskas, A., Kamperidis, N., Arebi, N., Farkas, B., Farkas, K., Pipek, B., Falt, P., Karmiris, K., Nikolaou, P., Krznaric, Z., Brinar, M., Hoentjen, F., Lierop, L. V., Acosta, M. B., Zaborowska, M., Zagorowicz, E., Pugliese, D., Cuccia, G., Truyens, M., & Kopylov, U. (2025). The effectiveness of second- and-third-line biologics in perianal Crohn’s disease—a multicenter propensity score-matched study. Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjaf099

Source records

crossref · retrieved 2026-09-26T09:52:06.865Z